Clinical Trial Update: Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial update reports completion of a study evaluating oxaliplatin (Eloxatin) plus 5-fluorouracil/leucovorin in patients with unresectable he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-FU/LV (5-fluorouracil with leucovorin)
• Eloxatin (oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED